The United States Pharmacopeia (USP), the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) and The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), have announced a research collaboration to assess analytical methods and develop standards for adeno-associated virus (AAV), an...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and BioPhorum Operations Group (BPOG) and have entered into a collaboration agreement to develop a US-specific roadmap for the biopharmaceutical manufacturing industry. The roadmap will complement the existing BPOG global roadmap.

The US-specific Roadmap will focus...

Amid an enthusiastic crowd of more than 400 attendees, the Advanced Regenerative Manufacturing Institute celebrated the start of its operations during an open house at its research facility in Manchester, New Hampshire on July 28. The BioFabUSA program looks to bridge the gap between early scientific research and later-stage product development by...